A substance derived from proteins in our stomach that can potentially control inflammation, aid in blood vessel formation, and modulate crucial signaling systems for healing seems like it could revolutionize recovery from injuries
Summary: Retatrutide and tesamorelin are both peptide-based compounds used in metabolic medicine, but retatrutide is an unapproved triple incretin receptor agonist in clinical trials, while tesamorelin is a GHRH analogue licensed in the US for HIV-associated lipodystrophy but unlicensed in the UK
These include bowel obstruction, chronic gallbladder disease, pancreatic cancer, liver failure, and other life-threatening diagnoses
And the science is still evolving
Fact: It is imperative to know the contraindications of Semaglutide in order to avoid severe complications
Setting this expectation honestly matters